PharVision Advisers’s Lithium Americas LAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30.9K Buy
+11,758
New +$36.1K 1.26% 27
2025
Q4
– Sell
-29,569
Closed -$169K – 861
2025
Q3
$169K Buy
+29,569
New +$93.4K 0.1% 551

Other funds holding LAC

PharVision Advisers's LAC Position: Q3 2026 in Review

PharVision Advisers opened a new position in Lithium Americas (LAC) in Q3 2026: 11,758 shares worth $30.9K. The stake represents 1.26% of the portfolio and ranks #27 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in LAC as recently as Q3 2025.

PharVision Advisers first reported a position in LAC in Q3 2025 and has held it in 2 quarters since. The position peaked at $169K in Q3 2025. 119 funds tracked by Wall St. Rank hold LAC as of Q3 2026.

  • PharVision Advisers held 11,758 shares of Lithium Americas worth $30.9K as of Q3 2026.
  • Lithium Americas was a new PharVision Advisers position in Q3 2026.
  • Lithium Americas made up 1.26% of PharVision Advisers's portfolio in Q3 2026, its #27 holding.
  • PharVision Advisers first reported a position in Lithium Americas in Q3 2025 and has held it in 2 quarters since.
  • PharVision Advisers's Lithium Americas position peaked at $169K in Q3 2025.
  • 119 funds tracked by Wall St. Rank held Lithium Americas as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.